Interleukin-13 is a more potent inhibitor of the expression of inducible nitric oxide synthase in smooth muscle cells than in macrophages: A comparison with interleukin-4 and interleukin-10

Shock

Volumn 8, Issue 6, 1997, Pages 409-414

  Ruetten, Hartmut ^a   Thiemermann, Christoph ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANE DERIVATIVE; ENDOTOXIN; ENZYME INHIBITOR; GAMMA INTERFERON; IMMUNOLOGICAL ADJUVANT; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITRIC OXIDE SYNTHASE; NITRITE; NOS2 PROTEIN, MOUSE; NOS2 PROTEIN, RAT; PHOSPHATIDYLINOSITOL 3 KINASE; TUMOR NECROSIS FACTOR ALPHA; WORTMANNIN;

ANIMAL; AORTA; ARTICLE; BIOSYNTHESIS; CELL LINE; CELL SURVIVAL; COMPARATIVE STUDY; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; IMMUNOLOGY; MACROPHAGE; MOUSE; RAT; VASCULAR SMOOTH MUSCLE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADJUVANTS, IMMUNOLOGIC; ANDROSTADIENES; ANIMALS; AORTA; CELL LINE; CELL SURVIVAL; ENDOTOXINS; ENZYME INHIBITORS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-13; INTERLEUKIN-4; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; RATS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031306639     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/00024382-199712000-00003     Document Type: Article

References (34)

1. Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med 329:2002-2012, 1993.
2. Drapier J, Wietxerbin J, Hibbs JB: Interferon gamma and tumour necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages. Eur J Immunol 18:1587-1591, 1988.
3. Bogdan C, Vodovotz Y, Paik J, Xie QW, Nathan C: Mechanism of suppression of nitric oxide synthase expression by interleukin-4 in primary mouse macrophages. J Leukocyte Biol 55:227-233, 1994.
4. Schneemann M, Schoedon G, Frei K, Schaffner A: Immunovascular communication: Activation and deactivation of murine endothelial cell nitric oxide synthase by cytokines. Immunol Lett 35:159-162, 1993.
5. Perretti M, Szabó C, Thiemermann C: Effect of interleukin-4 and inter leukin-10 on leucocyte migration and nitric oxide production in the mouse. Br J Pharmacol 116:2251-2257, 1995.
6. 2. Proc Natl Acad Sci USA 86:3803-3807, 1989.
7. Te Velde AA, Huijbens RJF, Heije K, De Vries JE, Figdor CG: Interleu- kin-4 (IL-4) inhibits secretion of IL-α, tumor necrosis factor-α and IL-6 by human monocytes. Blood 76:1392-1397, 1990.
8. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O’Garra A: IL-10 inhibits cytokine production by activated macrophages. J Immunol 147: 3815-3821, 1991.
9. De Waal Malefyt R, Abrams J, Bennet B, Figdor CG, De Vries JE: Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209-1220, 1991.
10. Vannier E, Miller LC, Dinarello CA: Coordinated antiinflammatory ef fects of interleukin 4: Interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor an tagonist. Proc Natl Acad Sci USA 89:4076-4080, 1992.
11. Moore KW, O’Garra A, De Waal Malefyt R, Vieira P, Mosmann TR: Interleukin-10. Annu Rev Immunol 11:165-190, 1993.
12. 2 production by lipopolysaccharide-stimulated monocytes. Int Immunol 6:661-667, 1994.
13. 2 production and antileishmanial capacity of human cultured mono cytes mediated by IFN-gamma. J Immunol 143:3020-3024, 1989.
14. Ho ASY, Liu Y, Khan TA, Hsu DH, Bazan JF, Moore KW: A receptor for interleukin-10 is related to interferon receptors. Proc Natl Acad Sci USA 90:11267-11270, 1993.
15. Keegan AD, Pierce JH: The interleukin-4 receptor: Signal transduction by a hematopoietin receptor. J Leukocyte Biol 55:272-276, 1994.
16. Zurawski SA, Chomarat P, Djossou O, et al: The primary binding subunit of the human interleukin-4 receptor is also a component of the interleu- kin-13 receptor. J Biol Chem 270:13869-13878, 1995.
17. Minty A, Chalon P, Derocq JM, et al: Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 362: 248-250, 1993.
18. McKenzie ANJ, Culpepper JA, De Waal Malefyt R, et al: Interleukin-13, a T-cell-derived cytokine that regulates human monocyte, B-cell function: Proc Natl Acad Sci USA 90:3735-3739, 1993.
19. Herbert JM, Savi P, Laplace MC, et al: IL-4 and IL-13 exhibit comparable abilities to reduce pyrogen-induced expression of procoagulant activity in endothelial cells and monocytes. FEBS Lett 328:268-270, 1993.
20. Derocq JM, Segui M, Poinot-Chazel C, et al: Interleukin-13 stimulates interleukin-6 production by human keratinocytes: Similarity with interleu kin-4. FEBS Lett 343:32-36, 1994.
21. De Waal Malefyt R, Figdor CG, Huijbens R, et al: Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes: Comparison with IL-4 and modulation by IFN-gamma or IL-10 .J Immunol 151:6370-6781, 1993.
22. Muzio M, Re F, Sironi M, et al: Interleukin-13 induces the production of interleukin-1 receptor antagonists (IL-1ra) and the expression of the mRNA for the intracellular (keratinocyte) form of IL-lra in human myelomonocytic cells. Blood 83:1738-1743, 1994.
23. Sozzani P, Cambon C, Vita N, et al: Interleukin-13 inhibits protein kinase C-triggered respiratory burst in human monocytes. J Biol Chem 270: 5084-5088, 1995.
24. Cocks BG, De Waal Malefyt R, Galizzi JP, De Vries JE, Aversa G: IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand. Int Immunol 5:657-663, 1993.
25. Punnonen J, Aversa G, Cocks BG, et al: Interleukin-13 induces interleu- kin-4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci USA 90:3730-3734, 1993.
26. Doyle AG, Herbein G, Montaner LJ, et al: Interleukin alters the activation state of murine macrophages in vitro: Comparison with interleukin-4 and interferon-gamma. Eur J Immunol 24:1441-1445, 1994.
27. Doherty TM, Kastelein R, Menon S, Andrade S, Coffman RL: Modulation of murine macrophage function by IL-13. J Immunol 151:7151-7160, 1993.
28. Saura M, Martinez-Dalmau R, Minty A, Perez-Sala D, Lamas S: Inter leukin-13 inhibits inducible nitric oxide synthase expression in human mesangial cells. Biochem J 313:641-646, 1996.
29. Szabó C, Thiemermann C: Regulation of the expression of inducible nitric oxide synthase. Adv Pharmacol 34:113-159, 1995.
30. Whittley KL, Ward SG, Kolios G, Westwick J: Interleukin-13 inhibits nitric oxide synthase induction by the activation of phosphatidylinositol- 3-kinase in HT-29 cells. Br J Pharmacol 1997. In press.
31. Green LC, Ruiz de Luzuriaga K, Wagner DA: Nitrate biosynthesis in man. Proc Natl Acad Sci USA 78:7764-7768, 1981.
32. Mossmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assay. J Immunol Methods 65:55-63, 1983.
33. Bryant, CE, Tomlinson A, Mitchel JA, Thiemermann C, Vane JR: Nitric oxide synthase in the rat fallopian tube is regulated during the estrous- cycle. J Endocrinol 146:149-157, 1995.
34. Thiemermann C: The role of the L-arginine: Nitric oxide pathway in circulatory shock. Adv Pharmacol 28:45-79, 1994.